169 related articles for article (PubMed ID: 24858422)
1. rIL-22 as an adjuvant enhances the immunogenicity of rGroEL in mice and its protective efficacy against S. Typhi and S. Typhimurium.
Kaur G; STS C; Nimker C; Bansal A
Cell Mol Immunol; 2015 Jan; 12(1):96-106. PubMed ID: 24858422
[TBL] [Abstract][Full Text] [Related]
2. Effect of adjuvants on immune response and protective immunity elicited by recombinant Hsp60 (GroEL) of Salmonella typhi against S. typhi infection.
Bansal A; Paliwal PK; Sagi SS; Sairam M
Mol Cell Biochem; 2010 Apr; 337(1-2):213-21. PubMed ID: 19851830
[TBL] [Abstract][Full Text] [Related]
3. Co-administration of rIpaB domain of Shigella with rGroEL of S. Typhi enhances the immune responses and protective efficacy against Shigella infection.
Chitradevi ST; Kaur G; Uppalapati S; Yadav A; Singh D; Bansal A
Cell Mol Immunol; 2015 Nov; 12(6):757-67. PubMed ID: 25640657
[TBL] [Abstract][Full Text] [Related]
4. Intraperitoneal immunization of recombinant HSP70 (DnaK) of Salmonella Typhi induces a predominant Th2 response and protective immunity in mice against lethal Salmonella infection.
Paliwal PK; Bansal A; Sagi SS; Sairam M
Vaccine; 2011 Sep; 29(38):6532-9. PubMed ID: 21767594
[TBL] [Abstract][Full Text] [Related]
5. Cloning, expression and characterization of heat shock protein 60 (groEL) of Salmonella enterica serovar Typhi and its role in protective immunity against lethal Salmonella infection in mice.
Paliwal PK; Bansal A; Sagi SS; Mustoori S; Govindaswamy I
Clin Immunol; 2008 Jan; 126(1):89-96. PubMed ID: 18024219
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of S. Typhi GroEL and IL-22 gene augments immune responses against Salmonella infection.
Kaur G; STS C; Nimker C; Singh M; Saraswat D; Saxena S; Bansal A
Immunol Cell Biol; 2013; 91(10):642-51. PubMed ID: 24145856
[TBL] [Abstract][Full Text] [Related]
7. Multi-epitope DnaK peptide vaccine accords protection against lethal S. typhimurium challenge: Elicits both cell mediated immunity and long-lasting serum-neutralizing antibody titers.
Verma S; Singh K; Bansal A
Pharmacol Res; 2021 Jul; 169():105652. PubMed ID: 33975015
[TBL] [Abstract][Full Text] [Related]
8. Development of recombinant vaccine candidate molecule against Shigella infection.
Chitradevi STS; Kaur G; Sivaramakrishna U; Singh D; Bansal A
Vaccine; 2016 Oct; 34(44):5376-5383. PubMed ID: 27591952
[TBL] [Abstract][Full Text] [Related]
9. A novel adjuvant, mixture of alum and the beta-adrenergic receptor antagonist propranolol, elicits both humoral and cellular immune responses for heat-killed Salmonella typhimurium vaccine.
Mazloomi E; Jazani NH; Shahabi S
Vaccine; 2012 Mar; 30(16):2640-6. PubMed ID: 22342704
[TBL] [Abstract][Full Text] [Related]
10. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
[TBL] [Abstract][Full Text] [Related]
11. Immunity to intracellular Salmonella depends on surface-associated antigens.
Barat S; Willer Y; Rizos K; Claudi B; Mazé A; Schemmer AK; Kirchhoff D; Schmidt A; Burton N; Bumann D
PLoS Pathog; 2012; 8(10):e1002966. PubMed ID: 23093937
[TBL] [Abstract][Full Text] [Related]
12. Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever.
Das S; Chowdhury R; Pal A; Okamoto K; Das S
Immunobiology; 2019 May; 224(3):371-382. PubMed ID: 30952553
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
Fotouhi F; Shaffifar M; Farahmand B; Shirian S; Saeidi M; Tabarraei A; Gorji A; Ghaemi A
Arch Virol; 2017 May; 162(5):1251-1260. PubMed ID: 28120096
[TBL] [Abstract][Full Text] [Related]
14. A novel adjuvant, a mixture of alum and the general opioid antagonist naloxone, elicits both humoral and cellular immune responses for heat-killed Salmonella typhimurium vaccine.
Jazani NH; Sohrabpour M; Mazloomi E; Shahabi S
FEMS Immunol Med Microbiol; 2011 Feb; 61(1):54-62. PubMed ID: 21054579
[TBL] [Abstract][Full Text] [Related]
15. Probiotic Bacteria and Their Cell Walls Induce Th1-Type Immunity Against
Lemme-Dumit JM; Cazorla SI; Perdigón GDV; Maldonado-Galdeano C
Front Immunol; 2021; 12():660854. PubMed ID: 34054825
[TBL] [Abstract][Full Text] [Related]
16. Naloxone and alum synergistically augment adjuvant activities of each other in a mouse vaccine model of Salmonella typhimurium infection.
Jazani NH; Parsania S; Sohrabpour M; Mazloomi E; Karimzad M; Shahabi S
Immunobiology; 2011 Jun; 216(6):744-51. PubMed ID: 21093956
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of two Salmonella typhimurium hybrids as challenge organisms in a system for the assay of typhoid vaccines.
Johnson EM; Diena BB; Lior H; Ryan A; Krol P; Baron LS
Infect Immun; 1982 Oct; 38(1):201-5. PubMed ID: 6754614
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of immunogenicity and protective efficacy of adjuvanted Salmonella Typhimurium ghost vaccine against salmonellosis in chickens.
Jawale CV; Lee JH
Vet Q; 2016 Sep; 36(3):130-6. PubMed ID: 26727359
[TBL] [Abstract][Full Text] [Related]
19. A recombinant protein of Salmonella Typhi induces humoral and cell-mediated immune responses including memory responses.
Das S; Chowdhury R; Ghosh S; Das S
Vaccine; 2017 Aug; 35(35 Pt B):4523-4531. PubMed ID: 28739115
[TBL] [Abstract][Full Text] [Related]
20. A novel approach for construction of an inactivated typhoid vaccine candidate that effectively augments both humoral and cellular immune responses.
Won G; Kim B; Lee JH
Vaccine; 2017 Jun; 35(25):3333-3341. PubMed ID: 28495314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
